Search

Your search keyword '"Nchinda, Aloysius"' showing total 134 results

Search Constraints

Start Over You searched for: Author "Nchinda, Aloysius" Remove constraint Author: "Nchinda, Aloysius"
134 results on '"Nchinda, Aloysius"'

Search Results

1. 1,3-Diarylpyrazolyl-acylsulfonamides as Potent Anti-tuberculosis Agents Targeting Cell Wall Biosynthesis in Mycobacterium tuberculosis

2. 1,3-Diarylpyrazolyl-acylsulfonamides as Potent Anti-tuberculosis Agents Targeting Cell Wall Biosynthesis in Mycobacterium tuberculosis

3. Positional-scanning combinatorial libraries of fluorescence resonance energy transfer peptides for defining substrate specificity of the angiotensin I-converting enzyme and development of selective C-domain substrates

6. Correction to “Identification of 2,4-Disubstituted Imidazopyridines as Hemozoin Formation Inhibitors with Fast-Killing Kinetics and In Vivo Efficacy in the Plasmodium falciparum NSG Mouse Model”

7. Identification of 2,4-Disubstituted Imidazopyridines as Hemozoin Formation Inhibitors with Fast-Killing Kinetics and In Vivo Efficacy in the Plasmodium falciparum NSG Mouse Model

8. Synthesis, Structure–Activity Relationship, and Mechanistic Studies of Aminoquinazolinones Displaying Antimycobacterial Activity

9. Lerisetron Analogues with Antimalarial Properties: Synthesis, Structure–Activity Relationship Studies, and Biological Assessment

10. Novel Antitubercular 6-Dialkylaminopyrimidine Carboxamides from Phenotypic Whole-Cell High Throughput Screening of a SoftFocus Library: Structure–Activity Relationship and Target Identification Studies

14. Erratum for Brunschwig et al., “UCT943, a Next-Generation Plasmodium falciparum PI4K Inhibitor Preclinical Candidate for the Treatment of Malaria”

15. Antimalarial Lead-Optimization Studies on a 2,6-Imidazopyridine Series within a Constrained Chemical Space To Circumvent Atypical Dose–Response Curves against Multidrug Resistant Parasite Strains

16. UCT943, a Next-Generation Plasmodium falciparum PI4K Inhibitor Preclinical Candidate for the Treatment of Malaria

17. Identification of Fast-Acting 2,6-Disubstituted Imidazopyridines That Are Efficacious in the in Vivo Humanized Plasmodium falciparum NODscidIL2Rγnull Mouse Model of Malaria

18. Identification of 2,4-Disubstituted Imidazopyridines as Hemozoin Formation Inhibitors with Fast-Killing Kinetics and In VivoEfficacy in the Plasmodium falciparumNSG Mouse Model

19. Identification of a Potential Antimalarial Drug Candidate from a Series of 2-Aminopyrazines by Optimization of Aqueous Solubility and Potency across the Parasite Life Cycle

20. Identification of Fast-Acting 2,6-Disubstituted Imidazopyridines That Are Efficacious in the in Vivo Humanized Plasmodium falciparum NODscidIL2Rγnull Mouse Model of Malaria.

21. Novel Antitubercular 6-Dialkylaminopyrimidine Carboxamides from Phenotypic Whole-Cell High Throughput Screening of a SoftFocus Library: Structure–Activity Relationship and Target Identification Studies

22. Medicinal Chemistry Optimization of Antiplasmodial Imidazopyridazine Hits from High Throughput Screening of a SoftFocus Kinase Library: Part 1

23. 2,4-Diaminothienopyrimidines as Orally Active Antimalarial Agents

24. Structure–Activity-Relationship Studies around the 2-Amino Group and Pyridine Core of Antimalarial 3,5-Diarylaminopyridines Lead to a Novel Series of Pyrazine Analogues with Oral in Vivo Activity

25. Structure–Activity Relationship Studies of Orally Active Antimalarial 3,5-Substituted 2-Aminopyridines

26. 3,5-Diaryl-2-aminopyridines as a Novel Class of Orally Active Antimalarials Demonstrating Single Dose Cure in Mice and Clinical Candidate Potential

27. Novel Orally Active Antimalarial Thiazoles

40. Medicinal Chemistry Optimizationof AntiplasmodialImidazopyridazine Hits from High Throughput Screening of a SoftFocusKinase Library: Part 1.

41. 2,4-Diaminothienopyrimidinesas Orally Active AntimalarialAgents.

42. Structure–Activity-RelationshipStudies aroundthe 2-Amino Group and Pyridine Core of Antimalarial 3,5-DiarylaminopyridinesLead to a Novel Series of Pyrazine Analogues with Oral in Vivo Activity.

43. Structure–ActivityRelationship Studies ofOrally Active Antimalarial 3,5-Substituted 2-Aminopyridines.

45. Chromone Studies. Part 11.1Synthesis and Electron-Impact Mass Spectrometric Study of Granulosin and Side-Chain Analogues†

47. Correction to “Identification of 2,4-Disubstituted Imidazopyridines as Hemozoin Formation Inhibitors with Fast-Killing Kinetics and In VivoEfficacy in the Plasmodium falciparumNSG Mouse Model”

48. Chromone Studies. Part 14.1Unprecedented Dimerisation of Chromone-3-Carbaldehyde-Derived Baylis–Hillman Adducts

49. Chromone studies. Part 10.1Substituent effects on the basicity of 2-(N,N-dimethylamino)chromones†

50. Erratum for Brunschwig et al., “UCT943, a Next-Generation Plasmodium falciparumPI4K Inhibitor Preclinical Candidate for the Treatment of Malaria”

Catalog

Books, media, physical & digital resources